Inactive Instrument

Press Releases F-star Therapeutics, Inc.

Equities

FSTX

US30315R1077

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

F star Therapeutics : Acquisition/Asset Disposal - Form 8-K	23-03-09	PU
F-STAR THERAPEUTICS, INC. : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	23-03-09	AQ
InvoX Pharma Completes Acquisition of F-star Therapeutics, Inc.	23-03-08	BU
F-STAR THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	23-03-07	AQ
F-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition by invoX Pharma	23-03-07	GL
F-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition by invoX Pharma	23-03-07	AQ
F-STAR THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	23-03-06	AQ
F-STAR THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	23-02-23	AQ
F-STAR THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	23-02-09	AQ
F-STAR THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	23-02-01	AQ
InvoX Pharma and F-star Therapeutics issue Joint Statement	23-01-26	GL
InvoX Pharma and F-star Therapeutics issue Joint Statement	23-01-26	GL
F-STAR THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	22-12-30	AQ
F star Therapeutics : Other Event - Form 8-K	22-12-29	PU
F-STAR THERAPEUTICS, INC. : Other Events (form 8-K)	22-12-29	AQ
F-STAR THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	22-12-21	AQ
F-STAR THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	22-12-19	AQ
F-star Therapeutics Presents Clinical Data on FS222, a CD137/PD-L1 Tetravalent Bispecific Antibody, at ESMO-IO 2022 Congress	22-12-06	GL
F-star Therapeutics Presents Clinical Data on FS222, a CD137/PD-L1 Tetravalent Bispecific Antibody, at ESMO-IO 2022 Congress	22-12-06	AQ
F-STAR THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	22-11-21	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases F-star Therapeutics, Inc.

Equities

FSTX

US30315R1077

Press Releases

Filters